Activity Overview
Pharmacists are an integral part of the interdisciplinary team that is critical in the management of pain. Increasingly involved in many aspects of patient care, pharmacists are uniquely positioned to contribute substantially to pain management in all settings and throughout the continuum of care,from acute treatment through chronic pain management. Managing pain has remained a challenge despite the availability of analgesics and tools to assist healthcare professionals in optimizing patient care. With approximately 25 million people experiencing acute pain each year due to injuries or surgery, and over 76 million experiencing chronic pain in the United States, the assessment and management skills of pharmacists must be continually updated.

This activity has been designed to specifically meet the needs of practicing pharmacists and will address current topics, emerging treatment options, and breaking scientific news, including the use of methadone and QT prolongation, the US Food and Drug Administration decision on propoxyphene, and a review of the Drug Enforcement Administration regulation in the Controlled Substance Act of 1970 governing the role and obligations of pharmacists. Could you be charged along with the medical provider for inappropriate or excessive use of controlled substances? Yes.

Agenda

10 minutes Introduction
J. Richard Brown, PharmD, FASHP (Chair)
33 minutes Treatment of Pain: Current Concepts
Robert L. Barkin, PharmD, MBA, FCP, DAAPM
33 minutes Managing Pain with Opiates: Strategies for Frontline Pharmacists
Bruce R. Canaday, PharmD, FASHP, FAPhA
15 minutes Question & Answer Session

Goal
This initiative has been designed to enhance community pharmacists’ understanding of the etiology and pharmacologic treatment of acute and chronic pain, to recognize drug-seeking behavior, to discover emerging therapies for the safe and effective treatment of pain, and to participate actively in the interdisciplinary team for optimal patient outcomes.

Intended Audience
This activity is designed for community pharmacists. No prerequisites required.

Learning Objectives
At the conclusion of this activity, the participant should be able to:

  • List 3 characteristics of acute and chronic pain, and the transitional stage in between.
  • Identify 2 barriers associated with opioid therapy (including addiction and pseudoaddiction) and methods to overcome these obstacles to optimize treatment.
  • Formulate strategies to address the clinical and psychological impact of inadequate pain management.

The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CE activity.

Accreditation Statement
The University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education to provide continuing education for pharmacists.

Credit Designation Statement
The University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Successful completion of this application-based educational activity will provide 1.5 contact hours credit (0.15 CEUs). A statement of CE credit will be available online immediately following successful completion of the activity. Successful completion includes taking the pre-test, attending the session, and completing the post-test and educational activity evaluation. ACPE Program # 064-000-09-206-L01-P.

Faculty
J. Richard Brown, PharmD, FASHP (Chair)
Professor
Colleges of Pharmacy and Medicine
University of Tennessee
Memphis, TN

Robert L. Barkin, PharmD, MBA, FCP, DAAPM
Professor, Rush Medical College
Faculty of Anesthesiology, Family Medicine, and Pharmacology
Rush University Medical Center
Clinical Pharmacologist
Northshore University Health System—Skokie, Evanston Hospitals, Pain Centers, and
 The Department of Anesthesiology
Chicago, IL

Bruce R. Canaday, PharmD, FASHP, FAPhA
Clinical Professor and Vice-Chair
Division of Pharmacy Practice and Experiential Education
University of North Carolina Eshelman School of Pharmacy
Chapel Hill, NC

Policy on Faculty and Provider Disclosure
It is the policy of The University of Tennessee College of Pharmacy that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during the presentation(s). Detailed disclosures will be made in the presentations.

Americans with Disabilities Act (ADA)
The University of Tennessee College of Pharmacy fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

Grievance Policy
A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of an educational activity sponsored or cosponsored by The University of Tennessee College of Pharmacy may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level review.

Fee Information
There is no fee for this educational activity.

Supported by an educational grant from PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
 
     
Home | Contact Us | View Account | Need Help? | Subscription